Andrew J. Kirsch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew J. Kirsch has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Angela M. Arlen
Pediatric Urology Department, Yale University School of Medicine, United States
2 shared publications- Benjamin Press
Department of Urology, Emory University School of Medicine, Atlanta, USA
2 shared publications - Christopher S. Cooper
Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
2 shared publications Edwin A. Smith
2 shared publications- Elizabeth Chu
Emory University School of Medicine, United States
2 shared publications - Adree Khondker
Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada; Division of Urology, Department of Surgery, The Hospital for Sick Children, Toronto, ON, Canada
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Elsevier in The Journal of the American Dental Association
Nocturnal enuresis and maxillary expansion
- 29 September 2026
- Published by Elsevier in The Journal of the American Dental Association
Open AccessNocturnal enuresis and maxillary expansion
- 24 September 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 23 (1)
Current practices and challenges in managing bedwetting: A multinational survey of pediatricians
- 24 September 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 23 (1)
Current practices and challenges in managing bedwetting: A multinational survey of pediatricians
- 7 February 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (3) , 105806
Clinical manifestations and management of prune-belly syndrome: A 20-year single center experience
- 7 February 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (3) , 105806
Clinical manifestations and management of prune-belly syndrome: A 20-year single center experience
- 2 May 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (4) , 999-1004
Early spontaneous resolution of vesicoureteral reflux from voiding cystourethrogram: A comparison of contemporary prediction models
- 2 May 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (4) , 999-1004
Early spontaneous resolution of vesicoureteral reflux from voiding cystourethrogram: A comparison of contemporary prediction models
- Open Access
Use of ChatGPT in Pediatric Urology and its Relevance in Clinical Practice: Is it useful?
Introduction: Artificial intelligence (AI) can be described as the combination of computer sciences and linguistics, objective building machines capable of performing various tasks that otherwise would need Human Intelligence. One of the many AI based tools that has gained popularity is the Chat-Generative Pre-Trained Transformer (ChatGPT). Due to the popularity and its massive media coverage, incorrect and misleading information provided by ChatGPT will have a profound impact on patient misinformation. Furthermore, it may cause mistreatment and misdiagnosis as ChatGPT can mislead physicians on the decision-making pathway. Objective: Eevaluate and assess the accuracy and reproducibility of ChatGPT answers regarding common pediatric urological diagnoses. Methods: ChatGPT 3.5 version was used. The questions asked for the program involved Primary Megaureter (pMU), Enuresis and Vesicoureteral Reflux (VUR). There were three queries for each topic, adding up to 9 in total. The queries were inserted into ChatGPT twice, and both responses were recorded to examine the reproducibility of ChatGPT’s answers. After that analysis, both questions were combined, forming a single answer. Afterwards, those responses were evaluated qualitatively by a board of three specialists with a deep expertise in the field. A descriptive analysis was performed. Results: ChatGPT demonstrated general knowledge on the researched topics, including the definition, diagnosis, and treatment of Enuresis, VUR and pMU. Regarding Enuresis, the provided definition was partially correct, as the generic response allowed for misinterpretation. As for the definition of VUR, the response was considered appropriate. And for pMU it was partially correct, lacking essential aspects of its definition such as the diameter of the dilatation of the ureter. Unnecessary exams were suggested, for both Enuresis and pMU. Regarding the treatment of the conditions mentioned, it specified treatments to Enuresis that are known to be ineffective, such as bladder training. Discussion: AI has a wide potential to bring several benefits to medical knowledge, improving decision-making and patient education. However, following the reports on the literature, we found a lack of genuine clinical experience and judgment from ChatGPT, performing well in less complex questions, yet with a steep decrease on its performance as the complexity of the queries increase. Therefore, providing wrong answers to crucial topics. Conclusion: ChatGPT responses present a combination of accurate and relevant information, but also incomplete, ambiguous and, occasionally, misleading details, especially regarding the treatment of the investigated diseases. Because of that, it is not recommended to make clinical decisions based exclusively on ChatGPT.
Open AccessUse of ChatGPT in Pediatric Urology and its Relevance in Clinical Practice: Is it useful?
Introduction: Artificial intelligence (AI) can be described as the combination of computer sciences and linguistics, objective building machines capable of performing various tasks that otherwise would need Human Intelligence. One of the many AI based tools that has gained popularity is the Chat-Generative Pre-Trained Transformer (ChatGPT). Due to the popularity and its massive media coverage, incorrect and misleading information provided by ChatGPT will have a profound impact on patient misinformation. Furthermore, it may cause mistreatment and misdiagnosis as ChatGPT can mislead physicians on the decision-making pathway. Objective: Eevaluate and assess the accuracy and reproducibility of ChatGPT answers regarding common pediatric urological diagnoses. Methods: ChatGPT 3.5 version was used. The questions asked for the program involved Primary Megaureter (pMU), Enuresis and Vesicoureteral Reflux (VUR). There were three queries for each topic, adding up to 9 in total. The queries were inserted into ChatGPT twice, and both responses were recorded to examine the reproducibility of ChatGPT’s answers. After that analysis, both questions were combined, forming a single answer. Afterwards, those responses were evaluated qualitatively by a board of three specialists with a deep expertise in the field. A descriptive analysis was performed. Results: ChatGPT demonstrated general knowledge on the researched topics, including the definition, diagnosis, and treatment of Enuresis, VUR and pMU. Regarding Enuresis, the provided definition was partially correct, as the generic response allowed for misinterpretation. As for the definition of VUR, the response was considered appropriate. And for pMU it was partially correct, lacking essential aspects of its definition such as the diameter of the dilatation of the ureter. Unnecessary exams were suggested, for both Enuresis and pMU. Regarding the treatment of the conditions mentioned, it specified treatments to Enuresis that are known to be ineffective, such as bladder training. Discussion: AI has a wide potential to bring several benefits to medical knowledge, improving decision-making and patient education. However, following the reports on the literature, we found a lack of genuine clinical experience and judgment from ChatGPT, performing well in less complex questions, yet with a steep decrease on its performance as the complexity of the queries increase. Therefore, providing wrong answers to crucial topics. Conclusion: ChatGPT responses present a combination of accurate and relevant information, but also incomplete, ambiguous and, occasionally, misleading details, especially regarding the treatment of the investigated diseases. Because of that, it is not recommended to make clinical decisions based exclusively on ChatGPT.
- 1 December 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (6) , 864-865
Parapelvic cyst: A rare cause of ureteropelvic junction obstruction in a pediatric patient managed with robotic cyst decortication
- 1 December 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (6) , 864-865
Parapelvic cyst: A rare cause of ureteropelvic junction obstruction in a pediatric patient managed with robotic cyst decortication
- Open Access
- 27 September 2019
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 7, 392
Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux
Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection for primary VUR with >5-year follow-up. Materials and Methods: Families of all patients who underwent Dx/HA injection for primary VUR at our institution between 2008 and 2012 were contacted for telephone interview. Data collected by phone included parental satisfaction and presence and severity of UTIs pre-operatively and post-operatively. Patient demographics, radiographic VUR data, need for secondary surgery, and surgical indications were obtained through chart review. Results: Five hundred and seventy-five patients underwent Dx/HA injection for primary VUR between 2008 and 2012. Ninety-nine (17.2%) of these patients' parents were successfully contacted and interviewed. Median follow-up time from surgery to survey was 8.4 (IQR 6.8–9.6) years. Secondary surgery was performed in 13/99 (13.1%), most commonly repeat Dx/HA injection. Seven patients (7.1%) underwent secondary Dx/HA injection for persistent VUR without UTIs at a median of 0.35 (IQR 0.33–0.77) years post-operatively. Five patients (5.1%) underwent Dx/HA injection (n = 3) or ureteral reimplantation (n = 2) for VUR with febrile UTIs (fUTIs) at a median of 2.2 (IQR 1.3–5.1) years. One patient had ureteral reimplantation for symptomatic obstruction 2.8 years after initial surgery. Only 3/99 (3.0%) required open or laparoscopic surgery after Dx/HA injection. Eighty-three families (84.7%) reported ≥1 fUTIs pre-operatively. Of these, only 9/83 (10.8%) reported fUTIs post-operatively, for an overall clinical success rate of 89.2%. Clinical success was 93.1% in patients whose pre-operative fUTIs were treated outpatient and 80.0% in those hospitalized at least once for fUTI treatment pre-operatively. Ninety-four percent of parents were highly satisfied, 2.4% partially satisfied, and 3.5% dissatisfied. Conclusions: Endoscopic injection with Dx/HA for primary VUR appears to have good long-term clinical success rates and high parental satisfaction, mirroring our previously reported short-term results. Post-operative ureteral obstruction is rare but may occur years post-operatively, justifying initial sonographic surveillance, and repeat imaging in symptomatic patients.
- 27 September 2019
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 7, 392
Open AccessLong-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux
Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection for primary VUR with >5-year follow-up. Materials and Methods: Families of all patients who underwent Dx/HA injection for primary VUR at our institution between 2008 and 2012 were contacted for telephone interview. Data collected by phone included parental satisfaction and presence and severity of UTIs pre-operatively and post-operatively. Patient demographics, radiographic VUR data, need for secondary surgery, and surgical indications were obtained through chart review. Results: Five hundred and seventy-five patients underwent Dx/HA injection for primary VUR between 2008 and 2012. Ninety-nine (17.2%) of these patients' parents were successfully contacted and interviewed. Median follow-up time from surgery to survey was 8.4 (IQR 6.8–9.6) years. Secondary surgery was performed in 13/99 (13.1%), most commonly repeat Dx/HA injection. Seven patients (7.1%) underwent secondary Dx/HA injection for persistent VUR without UTIs at a median of 0.35 (IQR 0.33–0.77) years post-operatively. Five patients (5.1%) underwent Dx/HA injection (n = 3) or ureteral reimplantation (n = 2) for VUR with febrile UTIs (fUTIs) at a median of 2.2 (IQR 1.3–5.1) years. One patient had ureteral reimplantation for symptomatic obstruction 2.8 years after initial surgery. Only 3/99 (3.0%) required open or laparoscopic surgery after Dx/HA injection. Eighty-three families (84.7%) reported ≥1 fUTIs pre-operatively. Of these, only 9/83 (10.8%) reported fUTIs post-operatively, for an overall clinical success rate of 89.2%. Clinical success was 93.1% in patients whose pre-operative fUTIs were treated outpatient and 80.0% in those hospitalized at least once for fUTI treatment pre-operatively. Ninety-four percent of parents were highly satisfied, 2.4% partially satisfied, and 3.5% dissatisfied. Conclusions: Endoscopic injection with Dx/HA for primary VUR appears to have good long-term clinical success rates and high parental satisfaction, mirroring our previously reported short-term results. Post-operative ureteral obstruction is rare but may occur years post-operatively, justifying initial sonographic surveillance, and repeat imaging in symptomatic patients.
- 1 April 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (4) , 1150-1157
Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months
The Vesicoureteral Reflux Index is a validated tool that reliably predicts spontaneous resolution of reflux or at least 2 grades of improvement for patients diagnosed before age 24 months. We evaluated the Vesicoureteral Reflux Index in children older than 2 years. Patients younger than 18 years who were diagnosed with primary vesicoureteral reflux after age 24 months and had undergone 2 or more voiding cystourethrograms were identified. Disease severity was scored using the Vesicoureteral Reflux Index, a 6-point scale based on gender, reflux grade, ureteral abnormalities and reflux timing. Proportional subdistribution hazard models for competing risks identified variables associated with resolution/improvement at different time points. A total of 21 males and 250 females met inclusion criteria. Mean ± SD age was 4.0 ± 2.1 years and patients had a median vesicoureteral reflux grade of 2. The Vesicoureteral Reflux Index score improved by 1 point in 1 patient (100%), 2 points in 25 (67.6%), 3 points in 48 (37%), 4 points in 18 (21.4%) and 5 to 6 points in 4 (18.2%). Female gender (p = 0.005) and vesicoureteral reflux timing (late filling, p = 0.002; early/mid filling, p <0.001) independently predicted nonresolution. Median resolution time based on Vesicoureteral Reflux Index score was 2 months or less in 15.6% of patients (95% CI 11.0-13.8), 3 months in 34.7% (95% CI 25.4-44.1), 4 months in 55.9% (95% CI 40.1 to infinity) and 5 months or more in 30.3% (95% CI 29.5 to infinity). High grade (IV or V) reflux was not associated with resolution at any point. Ureteral abnormalities were associated with lack of resolution in the first 12 to 18 months (HR 0.29, 95% CI 0.29-0.80) but not in later followup. Vesicoureteral Reflux Index scores of 3, 4 and 5 were significantly associated with lack of resolution/improvement compared to scores of 2 or less (p = 0.031). The Vesicoureteral Reflux Index reliably predicts primary vesicoureteral reflux improvement/resolution in children diagnosed after age 24 months. Spontaneous resolution/improvement is less likely as Vesicoureteral Reflux Index score and time from diagnosis increase.
- 1 April 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (4) , 1150-1157
Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months
The Vesicoureteral Reflux Index is a validated tool that reliably predicts spontaneous resolution of reflux or at least 2 grades of improvement for patients diagnosed before age 24 months. We evaluated the Vesicoureteral Reflux Index in children older than 2 years. Patients younger than 18 years who were diagnosed with primary vesicoureteral reflux after age 24 months and had undergone 2 or more voiding cystourethrograms were identified. Disease severity was scored using the Vesicoureteral Reflux Index, a 6-point scale based on gender, reflux grade, ureteral abnormalities and reflux timing. Proportional subdistribution hazard models for competing risks identified variables associated with resolution/improvement at different time points. A total of 21 males and 250 females met inclusion criteria. Mean ± SD age was 4.0 ± 2.1 years and patients had a median vesicoureteral reflux grade of 2. The Vesicoureteral Reflux Index score improved by 1 point in 1 patient (100%), 2 points in 25 (67.6%), 3 points in 48 (37%), 4 points in 18 (21.4%) and 5 to 6 points in 4 (18.2%). Female gender (p = 0.005) and vesicoureteral reflux timing (late filling, p = 0.002; early/mid filling, p <0.001) independently predicted nonresolution. Median resolution time based on Vesicoureteral Reflux Index score was 2 months or less in 15.6% of patients (95% CI 11.0-13.8), 3 months in 34.7% (95% CI 25.4-44.1), 4 months in 55.9% (95% CI 40.1 to infinity) and 5 months or more in 30.3% (95% CI 29.5 to infinity). High grade (IV or V) reflux was not associated with resolution at any point. Ureteral abnormalities were associated with lack of resolution in the first 12 to 18 months (HR 0.29, 95% CI 0.29-0.80) but not in later followup. Vesicoureteral Reflux Index scores of 3, 4 and 5 were significantly associated with lack of resolution/improvement compared to scores of 2 or less (p = 0.031). The Vesicoureteral Reflux Index reliably predicts primary vesicoureteral reflux improvement/resolution in children diagnosed after age 24 months. Spontaneous resolution/improvement is less likely as Vesicoureteral Reflux Index score and time from diagnosis increase.
- 1 April 2006
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 175 (4S) , 165
508: Scrotal Incision Orchiopexy for Undescended Testes with or without a Patent Processus Vaginaus
- 1 April 2006
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 175 (4S) , 165
508: Scrotal Incision Orchiopexy for Undescended Testes with or without a Patent Processus Vaginaus